Search Results - "BIERINGS, M"

Therapy of pediatric ALL relapsing after allogeneic transplant: how to make progress with limited patient numbers? by Bierings, M

Get full text

Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes by Peffault de Latour, R, Peters, C, Gibson, B, Strahm, B, Lankester, A, de Heredia, C D, Longoni, D, Fioredda, F, Locatelli, F, Yaniv, I, Wachowiak, J, Donadieu, J, Lawitschka, A, Bierings, M, Wlodarski, M, Corbacioglu, S, Bonanomi, S, Samarasinghe, S, Leblanc, T, Dufour, C, Dalle, J-H

“…Allogeneic hematopoietic stem cell transplantation (HSCT) offers the potential to cure patients with an inherited bone marrow failure syndrome (IBMFS)…”
Get full text

Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97 MRC AML12 protocol by van der Velden, V H J, van der Sluijs-Geling, A, Gibson, B E S, te Marvelde, J G, Hoogeveen, P G, Hop, W C J, Wheatley, K, Bierings, M B, Schuurhuis, G J, de Graaf, S S N, van Wering, E R, van Dongen, J J M

“…Analysis of minimal residual disease (MRD) in childhood acute myeloid leukemia (AML) may predict for clinical outcome. MRD levels were assessed by…”
Get full text

Outcome of invasive mechanical ventilation after pediatric allogeneic hematopoietic SCT: results from a prospective, multicenter registry by van Gestel, J P J, Bierings, M B, Dauger, S, Dalle, J-H, Pavlíček, P, Sedláček, P, Monteiro, L M, Lankester, A, Bollen, C W

“…Exact data on prognosis of children receiving invasive mechanical ventilation (IMV) after allogeneic hematopoietic SCT (HSCT) is lacking. We therefore started…”
Get full text

Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients by Hol, J A, Wolfs, T F W, Bierings, M B, Lindemans, C A, Versluys, A B J, Wildt de, A, Gerhardt, C E, Boelens, J J

“…This study was aimed at finding predictors of invasive fungal infection (IFI) after pediatric allogeneic hematopoietic SCT (HSCT). All children who received…”
Get full text

Refined characterization and reference values of the pediatric T- and B-cell compartments by van Gent, R, van Tilburg, C.M, Nibbelke, E.E, Otto, S.A, Gaiser, J.F, Janssens-Korpela, P.L, Sanders, E.A.M, Borghans, J.A.M, Wulffraat, N.M, Bierings, M.B, Bloem, A.C, Tesselaar, K

“…Abstract Work in the past years has led to a refined phenotypical description of functionally distinct T- and B-cell subsets. Since both lymphocyte…”
Get full text

Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes by Langenhorst, J.B., van Kesteren, C., van Maarseveen, E.M., Dorlo, T.P.C., Nierkens, S., Lindemans, C.A., de Witte, M.A., van Rhenen, A., Raijmakers, R., Bierings, M., Kuball, J., Huitema, A.D.R., Boelens, J.J.

“…Fludarabine is the most frequently used agent in conditioning regimens for allogeneic hematopoietic cell transplantation (HCT). Body surface area–based dosing…”
Get full text

Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study by Strahm, B, Nöllke, P, Zecca, M, Korthof, E T, Bierings, M, Furlan, I, Sedlacek, P, Chybicka, A, Schmugge, M, Bordon, V, Peters, C, O'Marcaigh, A, de Heredia, C D, Bergstraesser, E, Moerloose, B D, van den Heuvel-Eibrink, M M, Starý, J, Trebo, M, Wojcik, D, Niemeyer, C M, Locatelli, F

“…We report on the outcome of children with advanced primary myelodysplastic syndrome (MDS) transplanted from an HLA-matched sibling (MSD) or an unrelated donor…”
Get full text

Chronotyping glaucoma patients with the Munich ChronoType Questionnaire: A case-control study by Bierings, Ronald A J M, Gordijn, Marijke C M, Jansonius, Nomdo M

“…The circadian clock is entrained to light by the intrinsically photosensitive retinal ganglion cells. Loss of these cells in glaucoma, an eye disease with loss…”
Get full text

Population Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Prophylaxis in Pediatric Acute Lymphoblastic Leukemia Patients by Sassen, S D T, Mathôt, R A A, Pieters, R, de Haas, V, Kaspers, G J L, van den Bos, C, Tissing, W J E, te Loo, D M W W, Bierings, M B, van Westreenen, M, van der Sluis, I M, Zwaan, C M

“…Abstract Background Ciprofloxacin is used as antimicrobial prophylaxis in pediatric acute lymphoblastic leukemia (ALL) to decrease infections with…”
Get full text

Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004 by Kamps, W A, van der Pal-de Bruin, K M, Veerman, A J P, Fiocco, M, Bierings, M, Pieters, R

“…The Dutch Childhood Oncology Group (DCOG) has used two treatment strategies for children with acute lymphoblastic leukemia (ALL) based on Pinkel's St Jude…”
Get full text

Visual Performance as a Function of Luminance in Glaucoma: The De Vries-Rose, Weber's, and Ferry-Porter's Law by Bierings, Ronald A J M, de Boer, Marije H, Jansonius, Nomdo M

“…To determine whether the De Vries-Rose, Weber's, and Ferry-Porter's law, which describe visual performance as a function of luminance, also hold in patients…”
Get full text

Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells by te Boome, L C J, Mansilla, C, van der Wagen, L E, Lindemans, C A, Petersen, E J, Spierings, E, Thus, K A, Westinga, K, Plantinga, M, Bierings, M, Broers, A E C, Cuijpers, M L H, van Imhoff, G W, Janssen, J J, Huisman, C, Zeerleder, S, Huls, G, Boelens, J J, Wulffraat, N M, Slaper-Cortenbach, I C M, Kuball, J

“…We performed a prospective phase II study to evaluate clinical safety and outcome in 48 patients with steroid-refractory grade II–IV acute graft-versus-host…”
Get full text

Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation by LJUNGMAN, P, RIBAUD, P, CORDONNIER, And C, EYRICH, M, MATTHES-MARTIN, S, EINSELE, H, BLEAKLEY, M, MACHACZKA, M, BIERINGS, M, BOSI, A, GRATECOS, N

“…Adenovirus is an important cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation and there is no established therapy…”
Get full text

Leukemia-free survival in myeloid leukemia, but not in lymphoid leukemia, is predicted by early CD4+ reconstitution following unrelated cord blood transplantation in children: a multicenter retrospective cohort analysis by Admiraal, R, Chiesa, R, Lindemans, C A, Nierkens, S, Bierings, M B, Versluijs, A B, Hiwarkar, P, Furtado Silva, J M, Veys, P, Boelens, J J

Get full text

Loss of antibodies and response to (re-)vaccination in children after treatment for acute lymphocytic leukemia: a systematic review by VAN TILBURG, C. M, SANDERS, E. A. M, ROVERS, M. M, WOLFS, T. F. W, BIERINGS, M. B

“…Intensified chemotherapy regimens resulting in improved survival of children with acute lymphocytic leukemia (ALL) lead to concerns about therapy-induced…”
Get full text

Radiation exposure and mortality risk from CT and PET imaging of patients with malignant lymphoma by Nievelstein, R. A. J., Quarles van Ufford, H. M. E., Kwee, T. C., Bierings, M. B., Ludwig, I., Beek, F. J. A., de Klerk, J. M. H., Mali, W. P. Th. M., de Bruin, P. W., Geleijns, J.

“…Objective To quantify radiation exposure and mortality risk from computed tomography (CT) and positron emission tomography (PET) imaging with 18…”
Get full text

The pediatric acenocoumarol dosing algorithm: the Children Anticoagulation and Pharmacogenetics Study by Maagdenberg, H., Bierings, M. B., Ommen, C. H., Meer, F. J. M., Appel, I. M., Tamminga, R. Y. J., Cessie, S., Swen, J. J., Straaten, T., Boer, A., Maitland‐van der Zee, A. H.

“…Essentials A pediatric pharmacogenetic dosing algorithm for acenocoumarol has not yet been developed. We conducted a multicenter retrospective follow‐up study…”
Get full text

High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation by Marshall, G M, Dalla Pozza, L, Sutton, R, Ng, A, de Groot-Kruseman, H A, van der Velden, V H, Venn, N C, van den Berg, H, de Bont, E S J M, Maarten Egeler, R, Hoogerbrugge, P M, Kaspers, G J L, Bierings, M B, van der Schoot, E, van Dongen, J, Law, T, Cross, S, Mueller, H, de Haas, V, Haber, M, Révész, T, Alvaro, F, Suppiah, R, Norris, M D, Pieters, R

“…Children with acute lymphoblastic leukemia (ALL) and high minimal residual disease (MRD) levels after initial chemotherapy have a poor clinical outcome. In…”
Get full text

Impact of pretransplant minimal residual disease after cord blood transplantation for childhood acute lymphoblastic leukemia in remission: an Eurocord, PDWP–EBMT analysis by Ruggeri, A, Michel, G, Dalle, J-H, Caniglia, M, Locatelli, F, Campos, A, de Heredia, C D, Mohty, M, Hurtado, J M P, Bierings, M, Bittencourt, H, Mauad, M, Purtill, D, Cunha, R, Kabbara, N, Gluckman, E, Labopin, M, Peters, C, Rocha, V

“…To address the prognostic value of minimal residual disease (MRD) before unrelated cord blood transplantation (UCBT) in children with acute lymphoblastic…”
Get full text